Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_assertion type Assertion NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_head.
- NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_assertion wasGeneratedBy ECO_0000203 NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_provenance.
- NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_assertion wasDerivedFrom befree-20150227 NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_provenance.
- NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_assertion SIO_000772 21403679 NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_provenance.
- NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_assertion evidence source_evidence_literature NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_provenance.
- NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_assertion description "[Therapeutic targeting of Oct4(+)/TNC(+) progenitors may counteract the contribution of NB-derived ECs to tumor relapse and chemoresistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635951.RAXel_C9xtWrPPa_leDxbsjiJMHDKQizllzrOHar4vac8130_provenance.